The Bottom Line by Evolved Finance explores the financial journeys of some of the most successful online educators, thought leaders, influencers, and service providers in the online space. Each week, Parker sits down with a current Evolved Finance client to talk about their relationship with money and how their mindset has changed as their business has grown. This week, Parker chats with Erin Athene. Erin co-founded her first $20 million tech company in 17 months, and is now the co-founder of Mint C.R.O.,™ providing an Engineering Approach to Marketing™ along with her business partner and co-founder, Jessica Jobes. Mint C.R.O. has provided CRO training and expert coaching to hundreds of entrepreneurs and marketers to accelerate growth, improve lead quality and sales conversions, and reduce ad spend. Clients have achieved 2X to 10X repeatable growth using Mint CRO's systematic testing methodology, radically transforming their marketing results. To learn more about Evolved Finance: Follow us on iTunes and leave a review: https://podcasts.apple.com/us/podcast/evolved-finance/id1227529139 Download our free audio course: www.evolvedfinance.com/audiocourse Join our private Facebook Group: https://www.facebook.com/groups/evolvedfinance To learn more about Erin and her business: Mint CRO VIP gift: http://mintcro.com/dominate-now - use code: VIP-EVOLVED Instagram: https://www.instagram.com/erinathene/ LinkedIn: https://www.linkedin.com/in/erinathene/ Facebook: https://www.facebook.com/erinathene Twitter: https://twitter.com/erinathene
In part two this ASCO Education Podcast episode, hosts Dr. David Johnson and Dr. Patrick Loehrer continue their conversation with Dr. Richard Pazdur, director of the U.S. Food and Drug Administration's Oncology Center of Excellence, focusing on his leadership and vision for improving cancer care worldwide. The conversation includes reflection on drug toxicities, approval processes, and complexity of clinical trials. If you liked this episode, please subscribe. Learn more at https://education.asco.org, or email us at email@example.com. TRANSCRIPT Dr. Pat Loehrer: Hi. I'm Pat Loehrer, the Director of Global Oncology and Health Equity at Indiana University. Dr. Dave Johnson: And hi. I'm Dave Johnson at UT Southwestern in Dallas, Texas. Dr. Pat Loehrer: This is the second half of our Oncology, Etc. conversation with Dr. Rick Pazdur, who's the director of the FDA's Oncology Center of Excellence. In Part 1, we chatted with Dr. Pazdur about his upbringing and his early career. Today, we're going to focus on his leadership and vision for improving cancer care worldwide. But first, we'll discuss how cancer has impacted his life personally. I want to flash-forward. I had the pleasure of knowing Mary. And there was no question, if you had a problem in oncology, you would go to Mary and not Rick Pazdur when you were a house staff member. But moving forward a bit, I'm not sure if all the listeners know that Mary came down with ovarian cancer. Dave himself had cancer. My wife had breast cancer. It is incredibly hard to be an oncologist I think when your spouse or someone who's close to you has cancer, and particularly, being married to a medical oncology nurse. Maybe just share a little bit about that journey of being a husband of a- Dr. Richard Pazdur: Yeah. It is interesting because going back to the Rush story, the first patient that my wife and I had in common, and this is so ironic, was a patient with ovarian cancer. The last patient that we had in common was her, which is some ironic fate, so to speak. And the story began of her illness was right around Labor Day. We had gone to Chicago in February driving back from Chicago. I noticed that she kept on taking a whole bunch of Tums and then saying - Oh, I just got a lot of GI symptoms, and she went to see her gastroenterologist or GP and he said, ‘Oh, this is just, you know, indigestion.' And two weeks after that or not even that, she was in the hospital with a massive amount of ascites, needed an intensive care unit. It was readily apparent just on getting her CA 125 what she had and she wound up one day in debulking surgery and then IP chemotherapy, etc. I think something that I learned, and I think we knew from the very beginning that this was not going to be a curable illness, and how to deal with that on an emotional level. And I have to give my wife credit. She spared me a lot of the emotion because she was such a strong person. She made all of her own calls as far as what she wanted. She would ask me what I thought, but she would do her own research, she would go to her own doctors' appointments. She said, ‘You don't really need to come with me. I'm self-sufficient.' She was very much interested in helping other cancer patients, and after she died, I think one of the most cherished conversations I had was a group of women that came to me and said how much she helped them during their support group because she was a nurse. She knew she was dying. She had emotional maturity not to fall apart but to accept the inevitable in a very strong way. My wife was a very religious person, had gone to Catholic schools, really embraced religion during those terminal years basically. And I think that was a great sense of comfort to her. But it did teach me a lot of lessons when you take care of somebody that has cancer, and that is, what a bad job we do with drug toxicities. Drug toxicities to medical oncologists and especially the people at the FDA are numbered, Grade 3, Grade 4, Grade 1. These toxicities are tolerable, tolerable to who, so to speak. And how to manage these toxicities and how they interrupt your life is one of the lasting experience I have, which I always will remember. And that has been one of my roles recently is forming several programs that we have in the OCE to look at dosing, to look at what is this definition if the drug is tolerable or well-tolerated or if the toxicities could be managed. I always say, yeah, every toxicity could be managed, even death. You call the undertaker to manage it. So what do you really mean by that statement. But I think the issue of toxicity is an important one. And then also going on clinical trials and having people considering what you want to go on, what risk you want to take, and what is actually in the informed consent and how meaningful that is. Dr. Dave Johnson: Really glad you brought that up, Rick. That matches my own experience with lymphoma and going through chemotherapy. And as an oncologist, one would think I would know what the side effects are. I'd recounted them dozens and dozens of times to people over the years, but until you've actually experienced them either personally or up close as you did with Mary, it's impossible to fully understand. I'll give you one example. Fatigue. Everybody thinks they know what fatigue is, but until you've had chemotherapy-induced fatigue, the fatigue that never abates, you just don't understand what it is. It's debilitating in ways that are unimaginable to most people. So I'm sure that experience certainly shaped your view and your role at the FDA. Dr. Richard Pazdur: Correct. Dr. Dave Johnson: I wonder, if you might share, you initiated a number of programs recently, including programs to try to improve coordination and co-operation amongst the pharmaceutical companies. Could you speak to some of those programs for us? Dr. Richard Pazdur: I think one of my favorite programs is Project Orbis. Project Orbis is an idea I had when I was walking down the street. It just hit me. When I came to the FDA, one of the things I rapidly noticed is how isolated the FDA was, even from the rest from the regulatory agencies throughout the world. There was very little cross-fertilization there. So one of the very first things that I did was set up a monthly tele-conference first with the EMA, the European Medicines Agency, and then we ended on Health Canada, Australia, Japan, Singapore, you name it. And one of the things that became really apparent to me, we at the FDA got applications always first—always. That's obvious. You know why they had given it to us first? The money. That's where the finances are going to be. So we got the application first, and it could be 2 years, 18 months, 12 months, that these other countries, Canada, Australia, Switzerland, and Brazil, Israel, would get these applications. And I said, well, this isn't right, really, because these people, they have cancer. They have every right to get these medications as soon as possible, and also we have such a large agency. We have 80 to 100 oncologists that work there, and most of these agencies have one or two oncologists. So our expertise in oncology at the FDA is so much greater than these other regulatory agencies. How can we leverage that to help these other countries? So we started Project Orbis, and what it was is that companies come in and they submit an application and they simultaneously submit the same application to the countries that want to participate in the program. They are all preselected and have confidentiality agreements with each other. And we worked together on the applications, basically reviewing the applications. So we had many meetings, tele-conversations, telephone conversations with countries. So that expedites these drugs. This has really had a lasting impact because from a worldwide perspective, it's really promoted more rapid development of drugs and rapid approval of drugs, and that's important because that establishes sooner new standards of care that will impact future trials. So in addition to the humanitarian issue of improving healthcare for patients in these countries, it has an impact on the global clinical trial system by having new standards approved much faster and accepted by world authorities. Dr. Pat Loehrer: Let me just jump on that for a second, just to make a comment. Back when we were growing up, there would be like three to five drugs approved- Dr. Richard Pazdur: Yeah. Dr. Pat Loehrer: And today, it's like once a week, there's a new indication for oncologists. Dr. Dave Johnson: Our listeners have another question that might be appropriate to ask at this time. What is the most common mistake that drug companies make in their applications to the FDA or in the process of trying to get their drug approved? Is there a frequent mistake that you can advise them? Dr. Richard Pazdur: Well, they don't come and talk to us. That's number one. They want, not necessarily what the best registration pathway is, but what the quickest registration pathway is. And sometimes the quickest registration pathway, especially single arm trials, are not the best registrations pathway. So my advice is rather than playing games with the FDA, to put it in the vernacular, just do the right thing and say, what is the optimal information that patients need when I develop this drug. We're seeing a lot of problems now with various drugs where people are developing in a refractory disease setting a drug, and they plan on getting accelerated approval on a response rate. So they push and push the dose. And with a single arm study, you can't really evaluate safety that well. Everything is attributed to the drug, and they want to get the highest response rate. And they get it, and there's a confirmatory study, and the arm of the confirmatory study, the control arm may not be as toxic as theirs, and we're seeing a wave of drugs that now have inferior survival compared to controls, which probably is predicated upon, they got the wrong dose. And I think that is one of the major programs that we have, that we need to address is dosing in oncology, this ‘More is better, more is better,' and ‘Let's push the dose as high as possible.' More isn't even probably good in cytotoxic days, but certainly, not a good idea in targeted therapies and certainly not a good idea in biological therapy. So we've really got to think about dosing more, penetration of targets, what's the optimal dose rather than what's the highest dose. You know as well as I do, pharmaceutical companies want to go with the highest dose because the major hurdle is the demonstration of efficacy, even in a randomized study. So nobody wants to be blamed by saying, well, you spent $100 million on a Phase 3 study and it's negative because you used too low of a dose. But then at the end of the day, we don't have a really good tolerable dose, and it's really hard to go backwards and look at dosing after a drug was already approved because the efficacy study has already been done. Dr. Pat Loehrer: The other aspect of drug companies is not only getting the dosage there, but also the duration. There is motivation for money, and so patients are going to and- Dr. Richard Pazdur: Oh, count on that. Dr. Pat Loehrer: So it begs a question, and I know the FDA can't do this, but in other countries, there is a monetary review together with the toxicity review. Can you reflect a little bit about that to the best of your ability? Dr. Richard Pazdur: Well, even within our simpler agencies, they may communicate more than we do with CMS, but all oncology drugs that when they're approved are then paid for by CMS, okay? In these other countries, that is not so. They may get approval and then they have to go to these health assessment agencies that will decide and argue with the companies what the pricing of the drug is. I think it's a mistake, honestly, for the FDA to get into pricing. We have a hard enough time with efficacy and safety, and pricing is a very ephemeral concept because it could change on a dialing. Somebody could promise you, you should approve their drug because it's much cheaper on Monday, and on Friday, they could say, 'Oops, we made a mistake. We really think that this dose has to be X number of dollars.' And you could see competition hasn't worked well in oncology with seven PD-1 drugs approved, pricing has not really been of any movement here. Dr. Pat Loehrer: I'm sorry. Dave may have another question, but let me ask you this. Going back to the clinical trials and what industry asked you- the complexity of clinical trials is going up logarithmically compared to the way they were in the ‘70s and ‘80s. In many of the trials where we have to get all this data in order to soothe the FDA, what are your thoughts about simplifying clinical trials? Dr. Richard Pazdur: Oh yeah. I'm for it. I am for it. If you really look at it, these are not FDA requirements for the most part. The companies want them, all of this data because it's controlled. They don't want to be blamed at the end of the day for not capturing this data or that data. They have developed complicated bureaucracies, going back in my sociology days there, complicated bureaucracies to gather all of this data, the whole CRO industry to go out and pester you guys in practice by doing site visits. It's a complicated situation and it's really predicated a lot on the history and bureaucracies that have been built up and not money to strip away those bureaucracies for fear of failure, so to speak, of not catching something. Dr. Dave Johnson: So Rick, we're coming to the end of our time that we've scheduled. I actually have two questions for you. We've asked all of our previous guests, the first of which would be if you could talk to your 21-year-old self today, what advice would you give yourself? After you've done that, we'd like to know what books have you been reading lately or is there some documentary that you've seen that you would recommend to us and our listeners? Dr. Richard Pazdur: I would tell myself, when I was 21 years old, relax and be less anxious. All things pass. I think we get so anxious when we're young about relatively small things. I remember my first ASCO presentation, I was petrified. My heart was beating out of my chest. I was sweating. And like relax. It's one of a thousand presentations at ASCO. We tend to magnify things, and I think age puts things in perspective. This in the reality of the world is a small thing, and people probably won't even remember it. Dr. Dave Johnson: Excellent advice. Dr. Richard Pazdur: My favorite author that I'm reading now for the last couple of months is a presidential historical author, Doris Kearns Goodwin. I think many of you know, she's written many books. I love her writing style. And I like non-fiction. I like biographies and I like history books, history stories rather than mysteries or things like that, fantasy books. The two books that I really enjoyed, the first one was No Ordinary Time: Franklin and Eleanor Roosevelt: The Home Front in World War II. I don't know if anybody's read that. It's an excellent book. Most of our attention in World War II is directed toward Europe and what was going on in Europe, the battlefields, etc., which I'm not a big fan of reading about battles and stuff, but this was what was going on in The White House and the relationships of all of the people that came there. It was like a hotel almost with the personalities that were flowing through including Churchill and various princes and queens, etc. But also the interesting relation, the fascinating relationship that Eleanor and Franklin Roosevelt had, I don't know how to describe the relationship. It truly was an unconventional relationship based on some past history that they had of affairs etc., but it was just a fascinating one. The best book, though, again I'm reading now, is written also by Doris Kearns Goodwin, and it is Lyndon Johnson and the American Dream. Doris Kearns Johnson was his biographer and spent a great deal of time with him in The White House as well as when he left The White House. But it's an excellent book on management and reading people, success. One of the things that is most interesting about Lyndon Johnson, and especially when he was running the senate before he became president, was his ability to know what motivated people and how to use that to form a consensus. Does this person want to go on this trip. I'll give it to him and then he could help me with this. Does this person want to go to this party or get on this position in congress? So it was really a skillset that he had, which I think most leaders need to know. You have to motivate people. You can't lead by an autocratic masthead, but you've got to lead from what do people want and to make sure that they feel you have a personal relationship with them. As I say to my staff, everything in life is personal—everything. Dr. Dave Johnson: Well, it's been a great session, Rick. We so much appreciate your willingness to spend time with us. We wish we had twice as much time. I'm sure we could go on for hours. Thanks again, and we appreciate all you do at the FDA. You've been a fabulous leader, and we hope you continue on for many years to come. Dr. Richard Pazdur: Thank you so much, Dave, and thank you so much, Pat. Dr. Pat Loehrer: Great to see you. Dr. Dave Johnson: Pat, before we leave, any idea why our patients seem to get sick on Saturday and Sunday? Dr. Pat Loehrer: I have no clue. Do you know the answer, Dave? Dr. Dave Johnson: Yes. They have a weekend immunity. Thank you for listening to the ASCO Education Podcast. To stay up to date with the latest episodes, please click subscribe. Let us know what you think by leaving a review. For more information, visit the Comprehensive Education Center at education.asco.org. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.
Sterling Snow is the CRO of Divvy (Recently Acquired by Bill.com) and a revenue/leadership expert. He lives to help companies scale and grow and thrives on integrating sales, marketing, and customer success teams! Follow him on LinkedIn: https://www.linkedin.com/in/sterling-snow-051baab5/ And Divvy: https://getdivvy.com/ Join my Sales Mastermind Group for business owners and sales consultants - https://empatheticselling.com/ Music made by Qü ThaMusic - https://www.quthemusic.net/ The rest of my links to subscribe, support, and access more content - https://linktr.ee/daltonkjensen For the best health insurance talk to Norm - https://thehappyhealthinsuranceguy.com/ For all your digital marketing needs check out Monarch Social - https://monarchsocialbrand.com/
Today Ash and Rabah welcome Dylan Ander, founder of splittesting.com and one of the smartest minds in CRO. After $300M in sales for clients, he's here to share some of his secrets... Banger of an episode. If you liked this... Join 7500+ ecommerce marketers + operators and get marketing breakdowns, expert advice, and high-quality marketing resources straight to your inbox, right here. Follow Triple Whale on Twitter - https://twitter.com/triplewhale Follow Ash on Twitter - https://twitter.com/ashvinmelwani Follow Dylan on Twitter - https://twitter.com/Splittestingcom Follow Rabah on Twitter - https://twitter.com/rabahrahil See you next Monday at 9AM EST
Clari CEO Andy Byrne says he never wants to look back and see that he put more into his work than his family. But that doesn't mean he can't learn a thing or two from running a 600-person multi-billion dollar business: Inspired by business books, he and his wife Julie set goals, methods and OKRs for their family, and even asked their kids to grade them on how well they were hitting their targets. “I feel like our job is to help our families realize their fullest potential first, and then work is second,” Andy says.In this episode, Andy and Joubin discuss buying homes in San Francisco; leading a company when you have tragedy in your personal life; Man's Search For Meaning; internal vs. external expression; machine learning in enterprise; the “golden triangle” of reps, managers and execs; Andy's legendarily effective board meetings; how constraints create opportunity; and the metrics of marriage.In this episode, we cover: How luck makes you look smart (04:47) The “dark year” in Andy's life and coping with negative stimulus (09:51) Reframing seemingly huge problems as moments in time (16:27) How Clari helps CEOs and CROs answer “the most important question in business” (22:45) Getting from product fit to go-to-market fit (27:14) Leading a 600-person company, and Andy's fiduciary duty to their families (33:49) Actually, the CEO is not “the loneliest job in the world” (41:14) Managing through — and leaning into — a market downturn (45:00) Why Andy and his wife run their marriage like co-CEOs (49:24) Living your life with intention (56:00) Links: Connect with Andy Twitter LinkedIn Connect with Joubin Twitter LinkedIn Email: firstname.lastname@example.org Learn more about Kleiner Perkins
Justin and Jason discuss Jason's recent trip to Belize, Jason's literature review of SEO and CRO, Justin's work on the TaskFlow DOM and how to make it work in a real-time collaborative context, the latest with Math Academy, Jason's sleepy feet, and a little bit about various tv shows.
This week on the Maximize Business Value Podcast, we welcome back 17 percenter and CEO of Connect for Life, John Humphrey! You may remember John from our 17% club series a few weeks back, but this week John returns with some invaluable wisdom on how to 'Connect for Life!' Don't miss the chance to hear from one of the best, and don't forget to check out John's book, Connect for Life! John Humphrey is a serial entrepreneur with experience in starting businesses ranging from restaurants to software and consulting. John currently serves as Chief Executive Officer of Connect for Life and CRO for Sunvia. He has served in roles as Chief Revenue Officer and EVP of Cyber Group, Co-Founder and Chairman of the Board of Pariveda Solutions, a VP at Hitachi Consulting, and Partner at Tactica Technology Group. Tom Bronson is the founder and President of Mastery Partners, a company that helps business owners maximize business value, design exit strategy, and transition their business on their terms. Mastery utilizes proven techniques and strategies that dramatically improve business value that was developed during Tom's career 100 business transactions as either a business buyer or seller. As a business owner himself, he has been in your situation a hundred times, and he knows what it takes to craft the right strategy. Bronson is passionate about helping business owners and has the experience to do it. Want to chat more or think Tom can help you? Reach out at email@example.com or check out his book, Maximize Business Value, Begin with The Exit in Mind (2020).Mastery Partners, where our mission is to equip business owners to Maximize Business Value so they can transition their business on their terms. Our mission was born from the lessons we've learned from over 100 business transactions, which fuels our desire to share our experiences and wisdom so you can succeed.
João Vitor Santos Araujo é gaúcho de Porto Alegre, filho de ex-jogador do futsal do Inter e começou jogar bola também pelas quadras do time. Na adolescência, se viu na situação em ter que optar entre quadra e campo. Acabou migrando para o futebol dos gramados e em pouco tempo chegava num projeto que foi muito promissor: o Fragata. Com o crescimento e amadurecimento no time de Pelotas, esteve entre decidir jogar uma Copa São Paulo pelo Aimoré (RS) ou ir para a Europa e acabou optando pela segunda opção em 2017. Por cinco anos, dedicou-se a times da região de Lisboa, disputando a CNS (Campeonato de Portugal - antiga terceira divisão nacional). Na sua última passagem pelo Fabril Barreiro, o atacante gaúcho fez bons jogos, inclusive contra o Porto na Taça de Portugal e chamou a atenção de quem lhe abriria portas na Croácia para a temporada 21/22. Tendo atuado por dois clubes diferentes no período, por muito pouco não viu seu time (NK Rudes) chegar ao acesso à elite croata. Com contrato por mais uma temporada e otimista quanto ao acesso em 22/23, João gentilmente topou bater um papo para o canal, comentando sobre a carreira e os desafios que viu pelo mundo. #joaoaraujo #croacia #nkrudes
This week Ian Truscott and regular guest, rockstar strategy advisor Jeff Clark, former Research Director at SiriusDecisions/Forrester, take their monthly trip to the Rockstar CMO Swimming Pool, our portal to hell for all the BS, snake oil, and over-hyped trends that plague this industry we love. In this episode, they review a couple of nominations from Cathy McKnight and Harry Morton and discuss measuring the amount of content we put in the commoditized content sausage factory. This week's guest is Christopher P. Willis, Acrolinx's Chief Marketing Officer, who was last on the show in episode 85. Chris has over 20 years of experience growing companies in the technology sector and held leadership roles in marketing, creative, technical, and business development at companies including Perfecto, Pyxis Mobile, KPMG-CT, ModelGolf, and Cambridge Technology Group. Chris is a recognized thought leader in AI, DEI, and Content Governance. He is active within industry groups dedicated to the growth and health of Marketing Technology and the verticals he serves. Ian and Chris discuss his sales velocity metric, the role of the Chief Pipeline Officer, and the relationship between the CMO and CRO. Finally, we retire to the Rockstar CMO virtual bar, where Robert Rose tells a story about fish over a cocktail. The people: Ian Truscott on LinkedIn and Twitter Chris P. Willis on LinkedIn and Twitter Robert Rose on Twitter, LinkedIn, and The Content Advisory Mentioned in this week's episode: Previous interviews with Cathy McKnight (Episode 106) and Harry Morton (Episode 116) Last interview with Chris Willis Chris chatting with Drew Neisser on Renegade Marketers Unite Acrolinx Robert talks about the fish in water story in the CMI Newsletter Robert's The Content Advisory Blog Robert's latest project: Experience Advisory Rockstar CMO: Rockstar CMO on the web, Twitter, and LinkedIn Previous episodes and all show notes: Rockstar CMO FM Rockstar CMO Advisors Music: Piano Music is by Johnny Easton, shared under a creative commons license Stienski & Mass Media – We'll be right back on YouTube Too Much by the Dave Matthews Band on Spotify Learn more about your ad choices. Visit megaphone.fm/adchoices
Dave and Evan discuss how Crexendo is providing new options for enterprises and service providers with Jon Brinton, CRO of Crexendo. Jon triumphantly stepped in after a last minute scheduling change. That was probably for the best. Evan and I have known Jon for a long time, and those conversations always go a little smoother. Turns out he knows a few things about Crexendo too. Not to mention he shed some light on Mitel and Intertel history too. Crexendo Inc., is a full-service cloud communications provider that delivers critical voice and data communication services to small, medium, and small enterprise markets. Crexendo made a bold move last year with its acquisition of NetSapiens. A communications platform that is rapidly growing. It powers service providers around the globe, including Crexendo. Jon is a seasoned technology executive with over 25 years of industry experience, and is responsible for overseeing the strategy, performance and alignment of revenue generating operations for Crexendo. Prior to joining Crexendo, Jon most recently served as the Vice President of North America Channel for Avaya. At Avaya, he led the Channel through an exciting time of transition from traditional Premise Based solutions to Software as a Service and Cloud delivered solutions for Unified Communications, Collaboration and Customer Experience. During his tenure, the Avaya North America Channel achieved over $1 Billion in annual sales through growth and adoption of Cloud and Software as a Service delivered solutions.
Ele foi um triatleta com 10 participações em provas do Ironman, sendo 3 mundiais no Havaí. Formado em Administração e Marketing, é fundador e CEO da 7 Sherpas, agência de viagens customizadas para esportistas, e foi o criador do Ativo.com, a maior comunidade esportiva da América Latina. Meu outro convidado foi nadador e conquistou a 14. colocação nos 100m peito no mundial de 1986, foi medalha de bronze no revezamento 4x100m do Pan-Americano de 1987 e disputou os Jogos Olímpicos de 1988 em Seul. É formado em engenharia e CRO da Fyncom. Já atuou como vice-presidente do Credit Suisse no Brasil, além de ter fundado as fintechs Conductor, Paggo e Freeddom, especializadas em soluções para pagamentos eletrônicos. Eles estão aqui para contar como, depois de um encontro fortuito durante um passeio, eles decidem se unir para criar um novo negócio, que alia a paixão que ambos tem pelos esportes à tecnologia e ao desafio de se reinventar já na meio de suas vidas. Direto da ensolarada Califórnia, os idealizadores e criadores do Sportidia, uma startup que promete revolucionar o universo das redes sociais para os praticantes de esportes. Conosco aqui Hans Christian Kittler e seu sócio Cícero Antônio Xavier de Torteli, mais conhecido como Nico. Inspire-se! SIGA e COMPARTILHE o Endörfina através do seu app preferido de podcasts. Contribua também com este projeto através do Apoia.se. Um oferecimento também da Titanium Vida, Saúde e Previdência. Com 20 anos de história, o comprometimento total com seus clientes e uma alta credibilidade, a Titanium oferece as melhores soluções em proteção e segurança que você encontra no mercado, com planos de seguro de Vida, Saúde e Viagem. A Titanium oferece serviços para seu bem-estar, como o Seguro de Vida Resgatável, que além de resguardar e proteger o futuro das pessoas que você ama, te dá a opção de resgatar os valores em vida, e o Seguro Saúde com cobertura mundial e livre escolha de médicos, clínicas e hospitais. Colocar a Titanium em seu futuro é uma escolha sensata. Aproveite os melhores momentos da vida com quem você ama, livre de preocupações com o amanhã. Siga e conheça mais sobre a Titanium através do seu perfil no Instagram @titanium.consultoria. Não conte com a sorte, conte com a Titanium! Um oferecimento de @BOVEN_ENERGIA. Você conhece a Boven? Há mais de uma década, a Boven gerencia projetos e negocia a entrada de novos clientes no Mercado Livre de Energia. Com uma equipe experiente, a Boven se compromete com os bons resultados, atuando através de escritórios espalhados pelo Brasil. Descubra as vantagens de ser livre e saiba se sua empresa também pode ingressar nesse mercado. Seja livre, fale com a Boven. Boven, energia que inspira! Visite BOVEN.COM.BR e siga @BOVEN_ENERGIA.
„Wind of Change“ von den Scorpions, „The Times They Are a-Changin'“ von Bob Dylan oder „Changes“ von David Bowie – das Thema Change – Veränderung – wurde von zahlreichen Musikern aufgegriffen und unterschiedlich interpretiert und verarbeitet. Ähnlich verhält es sich auch mit dem Change im wirtschaftlichen Zusammenhang – auch hier gibt es zahlreiche unterschiedliche Herangehensweisen und Auslegungsarten. Aber Fakt ist: Noch nie mussten sich Unternehmen so schnell und so regelmäßig an interne als auch externe Veränderungen anpassen wie heute. Und jede Veränderung wirkt sich auch auf seine Mitarbeitenden aus. Gerade in Sondersituationen wie einer Restrukturierung oder Sanierung – in denen es mitunter zu extremen Veränderungen kommt – kommt daher dem Change Management daher eine große Bedeutung zu. Denn ohne eine Belegschaft und eine Führungsmannschaft, die bereit ist, die Veränderung mitzugehen, sind die beste Restrukturierungs- oder Sanierungsbemühungen aussichtslos. Nick Piepenburg von Turnaround Management Partners und Dr. Jürgen Erbe von Schultze & Braun, die schon viele Unternehmen durch Krisen geleitet haben, sprechen über die Bedeutung von Change Management in Sondersituationen und darüber, was eine gute Mischung aus Change und Prozess Management ausmacht.
Optimering af din shop eller hjemmeside er vigtigt. Det er ingen nok uenige om. Alligevel er der meget få, der arbejder med det, og endnu færre, der har sat det i system. Mikael har inviteret David Metzon i studiet til en dialog om, hvorfor CRO er vigtigt, men også hvorfor så mange muligvis undlader at bruge tid på det, selvom de ved, hvor vigtigt det kan være. Lyt med og hør, om du er en af dem, der kan gøre mere ud af CRO.
In this episode, we sit down with Spencer Burnett, a former seduction coach turned operations executive. He helps rapidly growing companies create systems and processes to ensure things don't break apart as they expand. We talk about the fundamentals of operations, how to help people maximize their efficiency (while actually working less), what it's like to go from a business owner to an employee, and much more. Growth is key to any business, but sometimes you need to take a step back to ensure your company is built for long-term success rather than just short-term profits. If you want to learn how to do this, watch the full episode! 0:00 Intro 1:20 How We Met Spencer 3:45 What Makes Someone Good At Managing Operations 9:00 How To Extract Information From People 12:00 Spencer's Story About His Seduction Coaching Business 14:30 Sales, Persuasion, And Influence 16:20 Being Unattached From A Sale 22:00 Difference Between A $50k/ Month $1 Million/ Month Company 25:40 The Hardest Part Of Going From An Owner To An Employee 31:40 How Spencer Freed up our CRO's time 37:00 How To Do More By Doing Less 43:10 The #1 Thing Spencer Wants To Achieve See omnystudio.com/listener for privacy information.
Drug developers face long odds and complex regulatory challenges when it comes to crafting a suitable candidate. In fact, only one of every 10 drug candidates gain regulatory approval, and when they do, it takes an average of 14 years and costs well over $2 billion. So what makes for a successful candidate? It starts with a suitable screening platform that identifies targets and the molecules that bind to them to create a therapeutic response. Retrogenix is one such platform that the top 20 drug developers in the world currently use to increase their chances of success thanks to its unique technology that doesn't require animal models or human tissue to evaluate effectiveness. Join us to find out how Retrogenix works to identify targets, accelerate drug development, get vulnerable patients the therapies they need more quickly, and adapt to meet the growing demands of regulatory agencies. Show Notes Charles River Acquires Retrogenix Retrogenix Cell Microarray Technology De-risking Therapies and Vaccines for Use During Pregnancy Assessing ADC Anticancer Therapeutics via Antibody Specificity Screening Screening and Profiling Assays Off-Target Screening Cell Microarray Assay Webinar: Building a comprehensive lead enabling library Poster: Off-target Assessment of Biotherapeutics for us During Pregnancy Case Study: Antibody Drug Conjugate Off-Target Binding Screen
In this episode, Jamie discusses: How she had over 15 years of clinical research experience before she landed her first CRA role and still struggled to get her foot in the door even with all of that experience How she was able to go straight from the site to a Sponsor CRA role The difference between being a CRA on the CRO side versus the sponsor side The complexities of dialysis studies How she was able to fast-track her career to the Senior CRA level How networking helped her progress in her career What to do after you start a role that isn't quite what you expected Life as a Clinical Operations Manager ***If you are ready to launch and take control of your career and break into your first CRA position (with no monitoring experience or certification), book a call with Jasmyn to learn more about she can help you! Visit www.AspiringCRA.com to book a call.
Jon talks about revenue growth with Brandi Starr and Rolly Keenan, authors of CMO to CRO. Brandi Starr is a marketing maven and author who brings two decades of experience into her role as the COO of Tegrita. A graduate of Penn State and the University of Phoenix, Brandi was recently named one of MartechExec's “50 Women You Need to Know in Martech”. She is a career strategist and speaker with an innate ability to leverage technology to drive success. Brandi was born with two teeth, ready to take a bite out of marketing and technology and chew through competition (#BornOverAchiever). Today, she resides in Atlanta, has a beautifully blended family of five children. When she's not making the magic happen, you can find Brandi on a plane, eating street tacos (#TacosAreLife), or spending time with her family. Rolly Keenan is a serial entrepreneur who splits his time between Chicago and Colorado. He is a born leader and the key growth specialist at Tegrita as our CRO. Rolly brings 20 years of leading growth at the likes of LinkedIn, Oracle, Gallup and the US Olympic Volleyball Team. Graduating from Northwestern University's Kellogg School of Management, Rolly is a trained hostage negotiator who is a partner to the wonderful, Veronica, and a father to six children and one dog, Nala. Connect with Jon Dwoskin: Twitter: @jdwoskin Facebook: https://www.facebook.com/jonathan.dwoskin Instagram: https://www.instagram.com/thejondwoskinexperience/ Website: https://jondwoskin.com/LinkedIn: https://www.linkedin.com/in/jondwoskin/ Email: firstname.lastname@example.org Get Jon's Book: The Think Big Movement: Grow your business big. Very Big! Connect with Brandi Starr and Rolly Keenan Website: http://revenuetakeover.com Twitter: https://twitter.com/revenuetakeover Instagram: https://www.instagram.com/revenuetakeover/ LinkedIn: https://www.linkedin.com/in/brandistarr/ Facebook: https://www.facebook.com/Revenuetakeover
In the early days of Okta, co-founder Frederic Kerrest was courting a 3,000-person company in Louisiana, which was considering Okta and one other vendor. When he learned who he was up against, he said, “We love competing with them ‘cause we beat them every time.” That arrogant boast lost him the deal, and taught him a humbling lesson: Your confidence is not superior to your customer's needs.In this episode, Frederic and Joubin discuss literally walking down memory lane in San Francisco, who his new book “Zero to IPO” is for, the value of time, the happiest nations on Earth, why Frederic prioritizes writing personal thank-you notes, why it's better to be lucky than good, pivoting to an upmarket strategy, the letdown of being at the top, the problem with “product-led growth” in enterprise, “sharpening the contradictions,” and staying present.In this episode, we cover: Why Frederic wrote “Zero to IPO,” and why he leads it with a story about failure (08:23) Entrepreneurship is a pie-eating contest (13:07) Frederic's direct communication style and the dichotomy between time and money (15:19) His passion for hockey, and why he used to park his car around the corner (24:35) Getting thrown out of two Okta board meetings in a row (29:03) Surviving awful quarters and service outages (36:10) How Frederic's arrogance lost him a huge early deal (42:20) Would he build a company from scratch all over again? (45:39) Why Frederic doesn't take phone calls on the weekends and the “oxygen mask rule” (54:06) “Nothing happens until somebody sells something” (57:20) Is Frederic personally affected by Okta's stock price? (01:02:09) The key players who receive a “ball bearing award” at Okta (01:07:22) How taking on additional projects and working with a professional coach has extended Frederic's time at Okta (01:11:48) Links: Connect with Frederic Twitter LinkedIn Connect with Joubin Twitter LinkedIn Email: email@example.com Learn more about Kleiner Perkins
We have to level up our business knowledge and tie community to how it ties into helping these business problems. Chris and Nicole talk about how it is so important to drive business outcomes from the community. If you want to be a leader in community, get close to the CMO, CCO, CRO, etc. Talk about how the community is solving problems for their point of view. We give some examples of how to dot hat.
Sábado Mariano XI Semana Tiempo Ordinario En la vida hay un conjunto de criterios que nos orientan para poder alcanzar el éxito o lograr un propósito que perseguimos... hoy la Palabra nos ilumina sobre un criterio que es fundamental para alcanzar la vida eterna y desde ya disfrutar la Paz en nuestro corazón...Lee los textos y descúbrelo 2 Cro 24, 17-25Sal 88, 4-5.29-34Mt 6, 24-34
This week Dann sits down with OP Ceramic Dealer Lambert Landry, CEO of Ceramic King Coatings and CRO of 10X Media and David Webber CEO of 10X Media and CMO of Ceramic King Coatings! Hear how they started each business and then melded the 2 bussinesses together. Now after having grown Ceramic King Coatings to 6 thriving locations, they made their own marketing company 10X Detail Media. Who better to market then people who intimatley know the industry?!? More proof that a true entreprenuer has to set down the buffer at some point to truley scale!
Kasim talks about the difference between primary and secondary conversion actions. He also shares how you can use secondary conversion actions for CRO and what you should be cautious about when selecting what to track. Google's definition of the two conversion actions: Primary actions: These are conversion actions that are reported in the “Conversions” column in your reports and used for bidding as long as the standard goal they are part of is used for bidding. Secondary actions: These conversion actions are for observation only. They are used for reporting in the “All conversions” column in your reports, but not for bidding, even if the goal they are included in is used for bidding. The one exception is if the secondary action is part of a custom goal. Read more about primary and secondary conversion actions here: https://www.youtube.com/redirect?event=video_description&redir_token=QUFFLUhqa3ZOTkRENTl1eGhLU3E1a3Qtak1lNlN4OTljd3xBQ3Jtc0ttWGtkUkFYSW1OMXpRV1pnVUs5Tm52d0s0NlVPbFd1T2N1S3Q0emZ0ZUtXVDNYa0VZNERmTE55OVAtSmZkdHlMMjBMS3RqZzMxRFlhakNrNld3UEpJcTVBaE9iczhfYmJWLWdmLURGdm9IZnFGRWRBNA&q=https%3A%2F%2Fsupport.google.com%2Fgoogle-ads%2Fanswer%2F11461796&v=pXEwywrXhNA (https://support.google.com/google-ads...) We just released our Performance Max Ultimate Guide blog that gives you everything you need to know about how to set up, build, and optimize your Google Ads Performance Max campaigns! Read the Performance Max Ultimate Guide here: https://www.youtube.com/redirect?event=video_description&redir_token=QUFFLUhqbEJ4T1d4amJwUWEzbGFMY1VpZWMwSDVoNjVzQXxBQ3Jtc0ttRjBLeWE4YmdwV3MwWEo5ZDdVUlVGeERxY3dYMmlzTFVzR19kbEFKekVuZk9zcnR4SUFDV25ucktLdVlLNDlHVm1ORkJSclNSSkktYWtBaXE2ZDA2MGNPQUJSSmNsNGotMjZ4SllhMnBZOUFIYktrdw&q=https%3A%2F%2Fsol8.com%2Fperformance-max-the-ultimate-guide%2F&v=pXEwywrXhNA (https://sol8.com/performance-max-the-...)
Beyond being the most entertaining guest we've had on the show, Jeanne Hopkins, CRO at OneScreen.ai & former CMO at Lola.com, convinced us that the Voice of Customer sync she designed is the most impactful meeting a leader can schedule. In this episode, Jeanne breaks down how the VOC meeting should be structured, which stakeholders to invite, and why an initiative like this can ensure that the voice of the customer is truly embedded into how a business runs. If you want better alignment around the customer at your company, this episode is a must-listen. Like Paul English, former CTO & co-founder of Kayak and Lola.com, said about Jeanne's meeting, “I've realized that our VOC meeting is not only my favorite meeting but has changed our product's direction and made our platform more customer-friendly than almost any single other thing we've done.”Resources: Connect with Jeanne on LinkedInRead why her VOC meeting was Paul English's favorite (former CTO & co-founder of Kayak and Lola.com) -------Adopt Customer-Led Growth todayTry Nuffsaid for free
Ah, the all-important fork-in-the-road moment: choosing a go-to-market motion. To settle the debate once and for all, we brought on Zhenya Loginov, CRO of Miro. He's seen GTM motions in action at Dropbox, Segment, and Miro. And has just the perspective you need to get this major decision right. In this episode of Reveal, Zhenya talks through how leaders should think about engineering and product, the important choice between a PLG and enterprise sales motion, and creating incentives to hire the absolute best talent.Join us for the Celebrate Reality Roadshow! https://gongh.it/celebrate-roadshow22-virtual
Alexi Robichaux is the Co-Founder and CEO of BetterUp, the first leadership development platform to connect coaching to sustainable behavior change. Prior to BetterUp, Alexi was Director of Product Management at VMware. Alexi is Chairman of Youth Leadership America (YLA), a nonprofit he co-founded in 2003, to foster peer-to-peer leadership development and civic engagement in high school students. YLA has collaborated with leading companies including Disney, Google, and Hilton Hotels to coach and mentor future leaders.This episode is chock-full of so many stories! We literally dive right into it, talking about what Navy Seals taught him about running his company, handling a cacophony of pain and misery, why it took him two years to hire a CRO, the frameworks he has in place to scale his business, and the mentors who have helped him learn them.To stay up to date on future episodes and learn more from Alisa, sign up for her newsletter!If you like what you hear, please subscribe to the podcast!Learn more about BetterUp at BetterUp.comFor more stories and advice on founders and CEOs, head to alisacohn.com
Gas Prices are nuts // Conway drives a $3800 SUV and he's losing confidence in it // Cro has a cross-country road trip coming up // When Conway gets home from a long drive he pats the car on the hood and thanks to it. // Stop things to check in on the officer shooting that took place in studio city // CHP Officer shot on Laurel Canyon //There is a certain Hospital that cops avoid by any means because of their notorious reputation
There is going to be a manhunt for the shooter // This is going to be a long night while CHP officers on the case for their comrade// Someone is lying about the weather. The phone app and the news say drastically different temps // The weather at Cro's // CHP Officer shooting – Car identified // CHP Officer Shooting // Eren got married and hasn't told a soul at KFI // Bigge=st shoes angel has made // Bellio got some good ones via email for the hotel // Cro takes a UV light to the hotel room // Conway is the wipe guy // Conway started this Purell business at KFI
In episode 115 of the Customers Who Click podcast I spoke with Jon MacDonald, Founder of thegood, a CRO agency in the States. They've been optimising sites for over 13 years now, helping brands grow not just through conversion rate optimisation, but also by improving average order values and lifetime value. Our mission is to remove all the bad experiences, so only the good remain. If you really focus on the customer experience, the customer journey, and what their goals are, thats only going to work in your favour. Too many brands try to put pressure on customers to complete a purchase through FOMO or scarcity, or just run promotions. When actually, going back to basics, understanding customers and communicating to them properly is whats needed. Jon is the Founder & CEO of thegood. You can connect with him on LinkedIn or head over to https://thegood.com/.
TL;DR If you love mac n' cheese and you haven't tried Goodles yet then you're in for a wild ride. Seriously, just had them this weekend and my tummy is happy and my body is thanking me. I invited Jen Zeszut, co-founder and CEO at Goodles, onto the show and we talked about how their small startup has grown so much, so fast. Prior to Goodles, Jen was CEO at Cerebelly (baby food for healthy brain development). Prior to that she was co-founder and CRO at Beckon (SaaS, raised $44M). Goodles was founded in 2021 (!), based out of Santa Cruz (CA) and has 24 people. Seed funding ($6.4M). Goodles is noodles, gooder. PROTEIN-PACKED, VEGGIE-BOOSTED mac n' cheese. Yum. Here's what we hit on: This is cool because Wonder Woman's Gal Gadot co-launched with you - why did you decide to bring her on the team? What were the results? How's it going; Why a celebrity is not the brand; How do you organize your marketing budget (HINT: we have "big noodles" or big rocks launching monthly); What marketing channels are you leaning into; Why you started the Make, Be and Do Gooder Community and how's it going; What content are you leaning into; Having a celebrity partner is like having a megaphone; How we measure what marketing content is working (HINT: we're pretty meticulous measurers and turn things on and off in a staggered way); What paid ads creative seems to be working the best for you (HINT: our ads are weird like the 3D rendering of cheese dripping); Why knowing "what is your soul" (why you do what you do) is so important for startups; What are your top marketing challenges; What are the last 1-2 really good, creative marketing ideas you've come up with (HINT: we're a lifestyle brand so we're selling all sorts of fun things like a stuffie and we just had a stuffie drop which was our biggest sales day other than launch day); Some goals you want to accomplish (personal, professional) in 2022 (HINT: it's not the focus on the outcome. Do great work with great people that you love working with. I'm bringing personal joy to my every day and we are laughing and joking and having a fun time. I feel like I can taste the joy in this food.) You can reach Jen on LinkedIn: https://www.linkedin.com/in/jenzeszut/ Find out more about Goodles: https://www.goodles.com/ For more content like this, subscribe to Modern Startup Marketing on Apple or Spotify or wherever you like to listen. You can find Anna on LinkedIn: www.linkedin.com/in/annafurmanov or visit this website: www.furmanovmarketing.com Thanks for listening! --- Send in a voice message: https://anchor.fm/anna-furmanov/message
Ah, the all-important fork-in-the-road moment: choosing a go-to-market motion. To settle the debate once and for all, we brought on Zhenya Loginov, CRO of Miro. He's seen GTM motions in action at Dropbox, Segment, and Miro. And has just the perspective you need to get this major decision right. In this episode of Reveal, Zhenya talks through how leaders should think about engineering and product, the important choice between a PLG and enterprise sales motion, and creating incentives to hire the absolute best talent.Join us for the Celebrate Reality Roadshow! https://gongh.it/celebrate-roadshow22-virtual
In April, a young girl was kidnapped and sexually assaulted in Yakima, Wash., and later told police she was picked up by a stranger in a car. The case might have gone cold there, if Yakima hadn't just installed Flock Safety cameras: The cameras were able to pinpoint a car matching the girl's description, and picked up the alleged abductor outside an elementary school campus, says Flock CEO Garrett Langley, who says stories like this have validated his company's mission of stopping crime in our communities.In this episode, Garrett and Joubin discuss a “huge life hack” that Garrett recommends to every CEO with young kids, quarter-life crises and how to rediscover your purpose, the biggest problem in public safety, how Flock Safety is solving thousands of crimes every year, the politics of surveillance camera placement, how Flock cameras became a feature of political campaigns, and how the company almost went out of business before its Series B.In this episode, we cover: Why Garrett's executive assistant is his mother (02:06) “I had no idea that people started companies” (13:07) Garrett's quarter-life crisis after two great startup exits (16:59) How Flock Safety helps law enforcement make communities safer (23:49) Solving a child abduction in Washington state (27:27) Why Garrett and his co-founders started Flock (31:22) The impact of Flock cameras on communities that don't trust the police (36:35) Political controversies and community engagement (39:18) Making cities safer and talent drain from local police departments (47:11) The challenges of fundraising for a police-tech startup in Atlanta (53:42) “Protect the whole community” (01:00:12) The public markets downturn (01:03:33) Links: Connect with Garrett Twitter LinkedIn Connect with Joubin Twitter LinkedIn Email: firstname.lastname@example.org Learn more about Kleiner Perkins
You likely feel the pain of getting more done in fewer hours. Maybe you need to hire people or have more work than people. No matter what is happening, work-life balance matters. Today's guest is Marc Reifenrath, CEO at Spinutech. Inc Magazine ranked its company #2700 on the 2021 Inc 5000 list. Spinutech is a full-service, all-digital marketing agency providing SEO, social, CRO, data/analytics, paid media, content, design, development, etc. Marc and I engage on why work-life balance matters. We look at where most people get it wrong. Join us for new insight on how work-life balance matters. Get the show notes for Work-Life Balance Matters Long-term with Marc Reifenrath at Spinutech Click to Tweet: Listening to a fantastic episode on Growth Think Tank featuring #MarcReifenrath with your host @GeneHammett https://bit.ly/gttMarcReifenrath #worklifebalancematters #GeneHammettPodcast #Inc2021 #GHepisode895 #digitalmarketingagency Give Growth Think Tank a review on iTunes!
U.A.P or U.F.O why change the name? / Probability of us being here // Cro and neils relationship / Neil came from kinkos / more alien talk // Neil and cro bond over space and nasa and buzz aldrin // wolf man creature / going out on a high note
Trying to navigate the financial world can be extremely challenging. Because of this, a lot of people turn to financial advisors for help with reaching their financial goals. But what should you expect while working with an advisor? In this episode, David Pulcini sits down with Matt Halloran, CRO and co-founder of ProudMouth, to talk … Continue reading Revealing the Unexpected and Unexplained While Working With a Financial Advisor with Matt Halloran, Podcasting Expert, CRO, & Co-Founder of ProudMouth (Ep.41) →
Last time Paul Taaffe came on the podcast, we heard how this former CFO has enjoyed extraordinary success running a boutique search firm. He revealed how he managed to bill €4,000,000 in revenue with a small team. Nearly two years later, Paul is back for his second appearance on the show. You'll hear fascinating insights on how to gain an advantage over the competition and outperform even the biggest search firms in the world. Paul's philosophy is about providing “return on energy invested.” He and his team provide an efficient service without compromising quality by leveraging their relationships and market knowledge. You'll learn how he achieves market mastery by carefully cultivating his network so he can deliver a shortlist in 30 days or less. On multiple occassions, Paul has made a €100,000 placement fee in 7 days! Paul is the founder and CEO of FINANCE People Solutions (FPS) based in Frankfurt, Germany. Prior to starting his business in 2014, he was either a CFO or CRO for US global corporations as well as high profile private equity funds and their portfolios where he mastered various change management challenges, from turnaround and restructuring to the implementation of new growth strategies. Episode Outline and Highlights [1:43] Paul shares the latest developments at his firm, Finance People Solutions. [6:15] FPS' focus market, revenue stream, and marketing strategy. [10:35] How to choose the right client to work with - and when to walk away. [15:30] Coaching your clients on their recruitment process [16:53] Paul's top tips on how to market a candidate. [20:36] FPS' new Benchmarking Products as a differentiator [23:30] Why Paul launched his own podcast. [27:26] Why ‘head-hunting' is an outdated term and Paul prefers ‘resource matching.' [33:58] How to build your brand on LinkedIn. [43:01] Paul reveals what he learned from working for Phil Knight, Nike's co-founder. [51:00] Why Paul likes to hire students when building his team Choosing the Right Clients Paul is a fan of positive energy which means he is selective of the clients he works with. He only works with committed clients, no contingency, only retained or exclusive. In our interview, Paul shared his criteria in client selection and when to ‘fire' or let go of a client. “If we do not enjoy working together, if the process is not good, in this day and age if you get your hands on top three candidates or two or even one for this matter, we never say we are going to produce a shortlist, we will produce at least one … and the customer is not coming back, not setting up appointments, not picking it up, that is no good we are wasting people's time,” is how Paul described it. He shared concrete examples based on experience how in some cases it did not work with some clients. Also, given the current situation in the market where recruitment needs to adapt, how do you coach your compatible clients on improving their recruitment process? Paul shares his best practices. Marketing and Brand Building Best Practices Although Paul's background is in finance, he is actually excellent at marketing. In this interview, you will hear some of his marketing strategies including: FPS Benchmarking Product Podcast Partnership with FINANCE Magazin LinkedIn content Paul believes US companies are the best at marketing and says his experience at Nike helped him to become a great marketer. Why Head-Hunting is a Term of the Past Another interesting topic we talked about is the term “headhunting” which Paul believes is outdated. As Paul said, “The difference for us is we have relationships with these people… That is why I don't like this term head-hunting… I call it resource matching. We match resources. We don't headhunt people, we have them already in our network. So it is about what is the best position for these people. So it is an evolution from the old headhunting.” Paul doesn't need to “hunt” because he's already mapped his market and curated a strong network. Since he already knows and has relationships with the vast majority of the candidates in his space, he is able to move fast without compromising quality. Our Sponsors This podcast is proudly sponsored by i-intro and Recruitment Entrepreneur. i-intro® is an end-to-end retained recruitment platform. Our technology and methodology allow recruiters to differentiate themselves from the competition, win more retained business, bigger fees and increase their billings. Be sure to mention Mark Whitby or The Resilient Recruiter for a 25% discount. Book your free, no-obligation consultation here: www.recruitmentcoach.com/retained We're excited to announce that Recruitment Entrepreneur will be sponsoring the podcast! If you've dreamed of starting up or scaling up and exiting your recruitment business, this is your chance. James Caan and his team at Recruitment Entrepreneur are actively seeking ambitious recruiters who they can invest in. Start a conversation here: https://www.recruitmentcoach.com/vc Paul Taaffe Bio and Contact Info Paul is the founder and CEO of FINANCE People Solutions (PFS) in 2014. He has been in the recruitment business since 2014, and prior to that, he was either a CFO or CRO for US global blue-chip companies such as Pepsi Cola, Nike, Lear Corporation, and Dell as well as having worked in Private Equity. He founded the PE Finance Organisation Benchmarking company, Taaffe and Partners in 2011. Paul on LinkedIn FINANCE People Solutions website link People and Resources Mentioned Joel Slenning on LinkedIn Shoe Dog, by Phil Knight Finance Magazin website link Connect with Mark Whitby Get your FREE 30-minute strategy call Mark on LinkedIn Mark on Twitter: @MarkWhitby Mark on Facebook Mark on Instagram: @RecruitmentCoach Related Podcast You Might Enjoy TRR#21 The Former CFO Turned Finance Recruiter Who Billed €4M Last Year, with Paul Taaffe TRR#53 How to Scale Your Staffing & Recruiting Firm to $16,000,000, With Joel Slenning Subscribe to The Resilient Recruiter
Voting has officially closed for the Mayoral Candidate // Rick Caruso has spent $40 million on his mayoral campaign // PCH improvements // Encino hospital stabber // Gavin Newsom is winning by 55% in his run // Recall was a colossal waste of money literally billions // Top Gun lawsuit after claimants attempt to come up financially // Voting Results – Alex Villanueva isn't looking the strongest with the votes // Bob Moon // Waiting for the Mayor race numbers // Cro daughter works at Disneyland // Mayors numbers come in // Collecting the numbers from across the elections
Fünf Top Learnings aus dem London-Consulting - Für Marketinganbieter Mein Geschäftspartner Dr. Rene Delpy und ich waren in London für ein intensives Consulting und einem Austausch mit Top Agenturen vor Ort. Über 30 neue Insights für Business, Marketing und Vertrieb haben wir mit in den Koffer gepackt. 5 Top Learnings erfährst du in der Podcastfolge. Bessere Kundenergebnisse im Marketing | Mehr finanzstarke Kunden gewinnen So gehen erfolgreiche Marketinganbieter mit psychologisch fundiertem Marketing dauerhaft in Führung und erreichen Top (Kunden- ) Ergebnisse.
Génesis 10: 25-321 Crónicas 1:19; Génesis 11:18, 11:1, 9:19, 10:1; Salmos 55:9, 145:18; Apocalipsis 1:1; 2 Cro 7:14-15; Proverbios 15:29; Santiago 5:16.“Escrituras tomadas de la Nueva Biblia de las Américas (NBLA), Copyright © 2005 por The Lockman Foundation. Usadas con permiso; todos los derechos reservados." www.NuevaBiblia.com
Leyla Seka has a clear idea of “what makes me great” as the COO of Ironclad: She's incredibly direct with her team. Although many people are not comfortable with getting direct feedback, she says, “I can't do my job if I can't tell you what I'm seeing.” And in the end, she sees her job as one of seeking out the truth, to make her business better.In this episode, Leyla and Joubin discuss developing peccadilloes as you get older, why a former boss told her “if you're in a bad mood, don't come to work,” what a COO actually does for her team, working through the first dotcom bust, why Leyla doesn't think she's better than anyone else, the long battle for equal pay, the “victim mindset” in the tech industry, empowering others who don't have confidence in themselves, and why you can't outwork every problem.In this episode, we cover: Maintaining a positive attitude, and dealing with low-energy days (07:57) “The culture of the company is why you stay” (12:02) Overthinking things, good communication and letting go of anxieties (17:50) Leyla's previous jobs and her parents' unusual careers (24:55) Keeping ego out of it and focusing on the “next best action” (31:10) Fighting for equal pay for women at Salesforce (39:19) The double-edged sword of innovation at Salesforce (49:19) How Leyla makes stars out of the underestimated people on her teams (55:40) Leaving Salesforce and starting Operator Collective (59:55) How she started working at Ironclad, and what the company does for customers (01:04:19) The biggest challenge Leyla has faced in her first six months at Ironclad (01:08:36) Links: Connect with Leyla Twitter LinkedIn Connect with Joubin Twitter LinkedIn Email: email@example.com Learn more about Kleiner Perkins
Welcome to another episode of The Action and Ambition Podcast! Joining us today is Will Basta, Co-Founder, and CRO at Ascend, an 8-figure logistics, and eCommerce company that builds, operates, and scales profitable online Businesses for their Clients. Ascend is on a mission to increase access to the 4.8 trillion dollar eCommerce market for investors looking to diversify their passive income investment portfolio. Tune in to learn more!
Sign up for our brand new 14-day Credit Hero Challenge.Hey everybody and welcome to this very special episode of Credit Repair Business Secrets!Today I'm not just going to talk about business bootstrapping… or hitting an 800+ credit score. Today's episode is much more important than that.In today's episode, I'm going to be sitting down to answer all of the questions that you guys have been asking me!I've asked you all to submit any kind of question you want me to answer about ANYTHING.Whether it's getting your business set up… marketing… or the client acquisition hacks you've never heard of before.No matter what stage you are in on your credit repair business journey… this video can help you hit your next milestone.So make sure to check it out!Key Takeaways:Intro (00:00)Our Facebook community spotlight (01:29)How much capital do you need to start a credit repair business? (03:02)How software can save you (07:05)Do you really need a website? (08:05)The truth about fulfillment (14:33)Striking a work/life balance (15:09)The best money-saving tips as a business owner (18:02)Do we need a CRO disclaimer? (23:50)The best email marketing strategy (26:10)Additional Resources:- Get a free trial to Credit Repair Cloud- Get my free credit repair training - Credit Hero Challenge - Free book- My Credit Repair site- State lawsMake sure to subscribe so you stay up to date with our latest episodes!
Mark Roberge is a leader in the sales world. He is currently co-founder of Stage 2 Capital, the first venture capital firm run and backed by over 300 GTM executives. He is also a Senior Lecturer at Harvard Business School. Prior to these roles, Mark served as founding CRO at HubSpot from $0 to IPO. He is author of best seller “The Sales Acceleration Formula” which became a guideline for start-up companies in growing their revenue and building a winning sales team. He's in the show to introduce to us his playbook which revolves around Product Led Growth for B2B startups. Get ready to learn some insightful lessons from this renowned industry expert. Show Notes [0:44] On creating a playbook for his PLG startup [3:32] The best of class teams have to set up a cross-functional team of marketing plus product and put it under the product [8:44] How category creation has become such an important part of entrepreneurship [12:27] PLG tends to focus the organization on usage first as opposed to revenues [14:03] The reason why free user attention is the hardest metric [14:49] Pro tip: Find a scalable, cost-effective way to generate users [16:35] Mark talks about the last part of the value metric, monetization [18:42] You don't start there as a seek funding business doing growth. [19:42] What the best class engineerings do is specialize their engineering teams and product teams by roadmap to improve growth [21:22] Create your growth team to be cross-functional with both product engineering plus marketing capabilities [21:36] Set your company up to be data-driven rapid experimentation, an organization that focuses on the Northstar About Mark Roberge As the SVP of Worldwide Sales and Services for HubSpot, he has led hundreds of his employees on how to apply data technology and inbound selling to every aspect of accelerating sales, including hiring, training, managing, and generating demand. Mark understands the ins and outs of marketing which is also a skill that he loves to share with others. Links Hubspot The Sales Acceleration Formula by Mark Roberge Profile Mark's LinkedIn
When Alex Norstrom started working at Spotify in 2011, CEO Daniel Ek told him there were three goals: Growth, growth, and growth. But Alex — now the Chief Freemium Business Officer — argued that his team would be better motivated by an “impossible goal,” something like reaching 100 million users. To which Daniel replied: “Let's do it. Your goal is to get us to 100 million users. Please begin.”In this episode, Alex and Joubin convene at Spotify's brand-new Stockholm studio to discuss his first job, the “shadow” mentorship program Alex runs, how Facebook changed everything for the gaming company King, thinking about the “bigger picture,” the tremendous effort happening behind the scenes before Spotify launched in each new country, “optimizing for surprises,” Joubin's embarrassing Spotify playlists, why we're still in the early innings of podcasting, Alex's lowest point at Spotify, partnering with FC Barcelona, and culture as currency.In this episode, we cover: The surprising lack of media coverage of Alex despite his prominence at Spotify (05:56) Working at his mother's Chinese restaurant and his relationship with food (12:21) The early “fiascos” in Alex's career, and how he came to work at Candy Crush Saga creator King (18:01) How Spotify CEO Daniel Ek convinced Alex to work for him (25:38) Why Alex has tried to set “impossible goals” since his first day at Spotify (28:40) Why the freemium business model works (34:21) Spotify's hardest and biggest market: The USA (38:39) Pivoting to a mobile-first strategy and the pricing trick that turned conversion numbers around (42:59) The invention of Discover Weekly, and Spotify's deep bench of other features (51:21) How Spotify got interested in podcasts, and the decision to put them in the same app with music (57:50) The odd but crucial lesson Alex learned early in his career: Stay near the laughter (01:06:46) Being ubiquitous on many platforms, and the art of pitching big & partnering smart (01:09:05) The end of free growth on the internet, and the power of Spotify Wrapped (01:15:07) Links: Connect with Alex Twitter LinkedIn Connect with Joubin Twitter LinkedIn Email: firstname.lastname@example.org Learn more about Kleiner Perkins
Brook Jackson has a near 20-year career spent in the clinical research industry working at individual clinical trial sites, SMOs, and CRO organizations. Her experience includes research in all phases of development for medical devices, pharmaceuticals, and biologics with key experience in Gastroenterology, Hepatology, Immunology, and Infectious Diseases. Brook's range of expertise has developed from her roles in clinical trial coordination and management, clinical trial monitoring, clinical trial auditing and director-level responsibility for quality control and assurance, regulatory compliance, and data management. On the podcast we discuss her speaking out about a Pfizer vaccine clinical trial with evidence suggesting it was fraught with problems, her conversations with Paul Thacker, some 80's movies and more. PLEASE SUBSCRIBE LIKE AND SHARE this podcast!!! Social Media https://twitter.com/IamBrookJackson
Steve Travaglini is the CRO at LinkSquares. Prior to that, he was a sales leader at OnShape and Datto, among other companies. In this episode, we discuss: Steve's transition from college football to sales The odd jobs he did before sales and how that transformed his mindset Getting through the ups and downs of sales How he's thinking about hiring during the Great Resignation And much more... If you enjoy the podcast, would you please consider leaving a short review on Apple Podcasts? It takes less than 60 seconds, and it really makes a difference in helping to grow this show and find the best guests possible for you. Follow The Podcast: Apple/Spotify: Millennial Sales Twitter: TommyTahoe Instagram: TommyTahoe YouTube: TommyTahoe Website: Millennialmomentum.net
In this episode of the Road to Growth podcast, we are pleased to introduce you to Oliver Feakins. Oliver is a serial entrepreneur of marketing-driven internet businesses. His history is rich with experience and is considered the local authority on Search Engine Optimization. He has founded and actively managed two successful digital businesses. Today Oliver owns two successful marketing companies - Trusted Search Marketing, a internet marketing agency that focuses on SEO, PPC, CRO and content marketing strategies, and TrackFive, a 7-figure online technology company that builds and manages intuitive web platforms that create a hub where employers and talent meet. TrackFive has almost 30 employees in their Florida and Pennsylvania offices and has won numerous awards including Central Penn's Business of the year, Fastest 50 growing companies and has earned a spot on the inc 5000. Oliver Co-Founded WebTalent Marketing, a digital marketing agency which focused on high- performing digital marketing campaigns including SEO and PPC marketing. He sold WebTalent Marketing in 2014 to focus on TrackFive. WebTalent Marketing caters to fortune 1000 clients as well as small businesses. Oliver has been recognized as a “40 under 40”, has spoken at over 20 national conferences and holds an MBA from LVC. When not growing businesses, tinkering in the land of marketing or impacting the community, Oliver teaches Entrepreneurialism at Millersville University and pilots planes with his newly minted pilots license. Lastly (and most importantly) Oliver is a father to a beautiful 18-month old little boy. Learn more and connect with Oliver Feakins by visiting him on Website: https://trustedsearchmarketing.com/ Linkdedin : https://www.linkedin.com/in/oliverfeakins/ Be sure to follow us on Twitter: Twitter.com/to_growth on Facebook: facebook.com/Road2Growth Subscribe to our podcast across the web: https://www.theenriquezgroup.com/blog Spotify: https://spoti.fi/2Cdmacc iTunes: https://apple.co/2F4zAcn Castbox: http://bit.ly/2F4NfQq Google Play: http://bit.ly/2TxUYQ2 Youtube: https://www.youtube.com/channel/UCKnzMRkl-PurAb32mCLCMeA?view_as=subscriber If you are looking to be a Guest on Podcasts please click below https://kitcaster.com/rtg/ For any San Diego Real Estate Questions Please Follow Us at web: www.TheEnriquezGroup.com Youtube: https://www.youtube.com/channel/UCKnzMRkl-PurAb32mCLCMeA or Call : 858 -345 - 7829 Recently reduced properties in San Diego County * Click **** bit.ly/3cbT65C **** Here* ****************************************************************************
Thrive CEO Arianna Huffington is best known for the pioneering online publication she founded, the Huffington Post, which she left in 2016. The experience of running the site awakened her to the most important problem she would tackle in her career: The intersecting crises of stress, burnout, poor sleep, and lack of focus, which Thrive teaches businesses how to manage.In this episode, Arianna and Joubin discuss how she went from a poor family in Greece to president of the elite Cambridge Union debate society; what she learned from both her parents, and the big lessons she has tried to impart to her own daughters; the hardships she faced professionally and personally before starting the Huffington Post; how she fell in love with online media, and how running the Huffington Post awakened her to the burnout epidemic; how Thrive is changing the conversation around stress; and the need for resilience-plus and the “obnoxious roommate in your head.”In this episode, we cover: Being present in every interaction is “one of the greatest gifts we can give each other” (02:23) Arianna's parents, and abundance as a function of your attitude to life (08:08) How she became the first foreign-born president of the Cambridge Union, which led to her first book (18:00) An “incredible gift”: Discovering at a young age that money and fame aren't always fulfilling (25:12) Running in the California recall election against Arnold Schwarzenegger, and a digital media epiphany (31:10) Burning out en route to Huffington Post's $300 million acquisition by AOL (36:53) Why Arianna launched a second startup in her 60s, and the mainstreaming of stress relief (41:35) The meaning of her 2022 word of the year, “resilience-plus” (48:22) How she has constantly re-invented herself, and metabolizing new experiences (55:04) Links: Connect with Arianna Twitter LinkedIn Email Thrive's head of recruiting, Keith Pescosolido: email@example.com Connect with Joubin Twitter LinkedIn Email: firstname.lastname@example.org Learn more about Kleiner Perkins